Case Study: Oncology Company Achieves ~80% Acceleration in Gene Target ID/ Validation

From paper to excel sheets, electronic lab notebooks, and finally to the cloud, biomedical data has been going places in the last few decades! As we transition into a post-cloud world and all your data is on the cloud, any AI initiative will be at risk unless the data is clean and linked to each other. In this session, Abhishek Jha elaborates on how Elucidata is doubling and tripling down on a data-centric approach to accelerate biological discovery.